TARSUS PHARMACEUTICALS, INC. (TARS) Operating income 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual operating income history from SEC filings — each fiscal year as reported.
-$71.0MFY2025 · since FY2019: -$4.3M → -$71.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$71.0M | +41.1% |
| FY2024 | -$120.6M | +15.8% |
| FY2023 | -$143.2M | -128.3% |
| FY2022 | -$62.7M | -415.9% |
| FY2021 | -$12.2M | +55.0% |
| FY2020 | -$27.0M | -528.2% |
| FY2019 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net incomeTARS Net marginTARS Gross profitTARS Gross marginTARS Operating marginTARS Operating cash flowTARS Free cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →